fbpx

PROLIGHT DIAGNOSTICS

Diagnostics you can count on

Prolight Diagnostics develops testing systems within POCT (Point of Care Testing). These tests are used outside of hospital laboratories to enable rapid assessments of patients’ health. The company’s POCT platform is under development with the aim of measuring multiple biomarkers simultaneously. A key focus of the work is to shorten the time to obtain test results, which is particularly important for patients with heart conditions.

RESEARCH

INFO ABOUT PROLIGHT 

CEO: Ulf Bladin

TICKER: PRLD

LIST: Nordic SME Sweden

WEB: https://prolightdx.com/en/

ANALYST

Johan Widmark

johan@emergers.se

+46739196641 

For new research on growth stocks, sign up to our newsletter